ALEXSANDRA LACHANCE: Open Payments
NPI 1023788445 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 27 payments from 14 companies in 2025. Trend: 2023 $992 · 2024 $545 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $124 |
| Olympus America Inc. | 3 | $90 |
| Endo USA, Inc. | 4 | $79 |
| Antares Pharma, Inc. | 3 | $62 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Verity Pharmaceuticals Inc. | 2 | $49 |
| IMMUNITYBIO, INC. | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: KEYTRUDA, iTIND System, XIAFLEX, XYOSTED, GEMTESA, Tlando, ANKTIVA, ADSTILADRIN.
Industry payments across MI — which companies pay providers there.
